Using mouse forward genetics to define novel target space

Drug Discovery Today: TARGETS

Volumn 1, Issue 4, 2002, Pages 130-138

  Hong, Nancy A ^a   Kay, Steve A ^a   Glynne, Richard J ^a  

^a Phenomix Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; ETHYLNITROSOUREA;

ALLELE; BIOENGINEERING; CHROMOSOME ANALYSIS; DATA ANALYSIS; DNA SEQUENCE; DRUG DETERMINATION; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; EVOLUTIONARY ADAPTATION; EXON; FUTUROLOGY; GENE CONSTRUCT; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE TARGETING; GENE TECHNOLOGY; GENE VECTOR; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENOME ANALYSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOASSAY; KNOCKOUT GENE; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEQUENCE DATABASE; STATISTICAL SIGNIFICANCE; TECHNIQUE; VALIDATION PROCESS;

EID: 15744405512     PISSN: 17418372     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1477-3627(02)02208-0     Document Type: Review

References (49)

1. Lander, E.S. et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921
2. Venter, J.C. et al. (2001) The sequence of the human genome. Science 291, 1304-1351
3. Gregory, S.G. et al. (2002) A physical map of the mouse genome. Nature 418, 743-750
4. Klinghoffer, R.A. et al. (2002) An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development. Dev. Cell 2, 103-113
5. Noveroske, J.K. et al. (2002) Quaking is essential for blood vessel development. Genesis 32, 218-230
6. Malmberg, A.B. et al. (1997) Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 278, 279-283
7. Chen, C. et al. (1995) Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC gamma mutant mice. Cell 83, 1233-1242
8. Giaever, G. et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387-391
9. Gonczy, P. et al. (2000) Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 408, 331-336
10. Wiles, M.V. et al. (2000) Establishment of a gene-trap sequence tag library to generate mutant mice from embryonic stem cells. Nat. Genet. 24, 13-14
11. Sadlack, B. et al. (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 15, 253-261
12. McCaffrey, A.P. et al. (2002) RNA interference in adult mice. Nature 418, 38-39
13. Lewis, D.L. et al. (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32, 107-108
14. Suzuki, T. et al. (2002) New genes involved in cancer identified by retro viral tagging. Nat. Genet. 32, 166-174
15. Ruivenkamp, C.A. et al. (2002) Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat. Genet. 31, 295-300
16. Callahan, R. and Smith, G.H. (2000) MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene 19, 992-1001
17. Justice, M.J. et al. (1999) Mouse ENU mutagenesis. Hum. Mol. Genet. 8, 1955-1963
18. Nolan, P.M. et al. (2000) A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 25, 440-443
19. Hrabe de Angelis, M.H. et al. (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25, 444-447
20. Balling, R. (2001) ENU mutagenesis: analyzing gene function in mice. Annu. Rev. Genomics Hum. Genet. 2, 463-492
21. Geissler, E.N. et al. (1988) The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55. 185-192
22. Nehls, M. et al. (1994) New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 372, 103-107
23. Richie, E.R. et al. (2002) The Polycomb-group gene eed regulates thymocyte differentiation and suppresses the development of carcinogen-induced T-cell lymphomas. Oncogene 21, 299-306
24. Herron, B.J. et al. (2002) Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. Nat. Genet. 30, 185-189
25. Kasarskis, A. et al. (1998) A phenotype-based screen for embryonic lethal mutations in the mouse. Proc. Natl. Acad. Sci. U. S. A. 95, 7485-7490
26. Geyer, M.A. et al. (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl.) 156, 117-154
27. Cormier, R.T. et al. (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 17, 88-91
28. Silverman, K.A. et al. (2002) Identification of the modifier of Min 2 (Mom 2) locus, a new mutation that influences Ape-induced intestinal neoplasia. Genome Res. 12, 88-97
29. Cormier, R.T. et al. (2000) The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 19, 3182-3192
30. McDonald, J.D. et al. (1990) Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc. Natl. Acad. Sci. U. S. A. 87, 1965-1967
31. Antoch, M.P. et al. (1997) Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell 89, 655-667
32. King, D.P. et al. (1997) Positional cloning of the mouse circadian clock gene. Cell 89, 641-653
33. Bodnar, J. S. et al. (2002) Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 30, 110-116
34. Groden, J. et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589-600
35. Nishisho, I. et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665-669
36. Su, L.K. et al. (1992) Multiple intestinal neoplasia caused by amutation in the murine homolog of the APC gene. Science 256, 668-670
37. Kurima, K. et al. (2002) Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat. Genet. 30, 277-284
38. Vreugde, S. et al. (2002) Beethoven, a mouse model for dominant, progressive hearing loss DFNA36. Nat. Genet. 30, 257-258
39. Dietrich, W.F. et al. (1996) A comprehensive genetic map of the mouse genome. Nature 380, 149-152
40. Dietrich, W.F. et al. (1994) Agenetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat. Genet. 7, 220-245
41. Loots, G.G. et al. (2000) Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288, 136-140
42. Benacerraf, B. and McDevitt, H.O. (1972) Histocompatibility-linked immune response genes. Science 175, 273-279
43. Bell, G.I. et al. (1984) A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33, 176-183
44. Todd, J.A. and Wicker, L.S. (2001) Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15, 387-395
45. Shoelson, S. et al. (1983) Three mutant insulins in man. Nature 302, 540-543
46. Hani, E.H. et al. (1999) Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J. Clin. Invest. 104, R41-R48
47. Hani, E.H. et al. (1998) Amissense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J. Clin. Invest. 101, 521-526
48. Stroll, M. et al. (2001) A genomic-systems biology map for cardiovascular function. Science 294, 1723-1726
49. Rogers, D.C. et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 8, 711-713